388 related articles for article (PubMed ID: 8562725)
1. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
Röther J; Jakob J; Bender HJ; Hewer W
Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
[TBL] [Abstract][Full Text] [Related]
2. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
4. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome: a case report.
Fekadu A; Wakwoya A
Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic Malignant syndrome (NMS): a rare presentation induced by an antiemetic - case report.
Kashyap GL; Patel AG
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S43-5. PubMed ID: 21894101
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
Rock W; Elias M; Lev A; Saliba WR
Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
[TBL] [Abstract][Full Text] [Related]
8. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
9. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome.
McHugh TP
J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
Liam CK; Ong SB
Singapore Med J; 1990 Apr; 31(2):182-4. PubMed ID: 1973548
[TBL] [Abstract][Full Text] [Related]
12. [The neuroleptic malignant syndrome].
Dammers S; Zeit T; Leonhardt M; Schär V; Agelink MW
Dtsch Med Wochenschr; 1995 Dec; 120(50):1739-42. PubMed ID: 8542810
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Sokoro AA; Zivot J; Ariano RE
Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
Margetić B; Aukst-Margetić B
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptic malignant syndrome--a case report].
Lanczik M; Fritze J
Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
[TBL] [Abstract][Full Text] [Related]
16. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
Bellamy CJ; Kane-Gill SL; Falcione BA; Seybert AL
J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
[TBL] [Abstract][Full Text] [Related]
18. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
20. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
Hermle L; Oepen G
Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
